Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Cost of Revenue (2024 - 2025)

Carlsmed (CARL) has disclosed Cost of Revenue for 2 consecutive years, with $3.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cost of Revenue fell 52.48% year-over-year to $3.1 million, compared with a TTM value of $2.5 million through Sep 2025, changed N/A, and an annual FY2025 reading of $35.0 million, up 653.43% over the prior year.
  • Cost of Revenue was $3.1 million for Q3 2025 at Carlsmed, down from $3.2 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $6.6 million in Q3 2024 and bottomed at -$10.4 million in Q4 2024.